Quantedge Capital’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,520
| Closed | -$146K | – | 92 |
|
|
2025
Q1 | $146K | Buy |
+11,520
| New | +$146K | 0.05% | 103 |
|
|
2024
Q4 | – | Sell |
-13,220
| Closed | -$199K | – | 171 |
|
|
2024
Q3 | $199K | Sell |
13,220
-50,200
| -79% | -$757K | 0.06% | 170 |
|
|
2024
Q2 | $899K | Sell |
63,420
-21,700
| -25% | -$307K | 0.32% | 78 |
|
|
2024
Q1 | $1.16M | Sell |
85,120
-38,000
| -31% | -$518K | 0.49% | 53 |
|
|
2023
Q4 | $1.66M | Buy |
123,120
+28,700
| +30% | +$386K | 0.81% | 35 |
|
|
2023
Q3 | $1.18M | Buy |
94,420
+35,700
| +61% | +$445K | 0.64% | 46 |
|
|
2023
Q2 | $795K | Buy |
58,720
+33,200
| +130% | +$450K | 0.35% | 74 |
|
|
2023
Q1 | $355K | Buy |
25,520
+8,300
| +48% | +$116K | 0.14% | 101 |
|
|
2022
Q4 | $245K | Buy |
+17,220
| New | +$245K | 0.08% | 144 |
|
|
2021
Q1 | – | Sell |
-18,403
| Closed | -$363K | – | 100 |
|
|
2020
Q4 | $363K | Buy |
+18,403
| New | +$363K | 0.21% | 83 |
|